Current Atherosclerosis Reports

Papers
(The TQCC of Current Atherosclerosis Reports is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-07-01 to 2025-07-01.)
ArticleCitations
Revascularization Options for Left Main Disease: What Clinicians Need to Know135
Are Clinicians Aggressive Enough in Treating Diabetes-Related Hyperlipidemia in Youth?82
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American Heart Association Scientific Sessions78
Polysocial Risk Scores: Implications for Cardiovascular Disease Risk Assessment and Management77
Whether and Why Do We Need a Vaccine Against Atherosclerosis? Can We Expect It Anytime Soon?71
The Greatly Under-Represented Role of Smooth Muscle Cells in Atherosclerosis68
A Narrative Review of the Association Between Depression and Heart Disease Among Women: Prevalence, Mechanisms of Action, and Treatment60
Heart Transplant, Kawasaki Disease, and Bone Marrow Transplant: Are There Consequences?55
PCSK9 Inhibition and Risk of Diabetes: Should We Worry?55
Glucagon-Like Peptide 1 Receptor Agonists: A Medication for Obesity Management54
Ambient Air Pollution and Atherosclerosis: Recent Updates54
Watermelon and l-Citrulline in Cardio-Metabolic Health: Review of the Evidence 2000–202051
The Effects of FABP4 on Cardiovascular Disease in the Aging Population49
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women48
DOACs and Atherosclerotic Cardiovascular Disease Management: Can We Find the Right Balance Between Efficacy and Harm47
Myocardial Infarction in the Absence of Obstructive Coronary Artery Disease (MINOCA): a Review of the Present and Preview of the Future45
Genetic Testing for Familial Hypercholesterolemia in Clinical Practice41
From ‘Omics to Multi-omics Technologies: the Discovery of Novel Causal Mediators40
Programmable Genome-Editing Technologies as Single-Course Therapeutics for Atherosclerotic Cardiovascular Disease39
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond39
The Emerging Specialty of Cardio-Rheumatology39
Percutaneous Coronary Interventions in Women36
Inflammation in the Peri-ACS Period: Ready for Prime Time?36
Nutrition Interventions for Youth with Dyslipidemia: Who, What, When, and Where?34
Correction to: Beta‑blockers for Atherosclerosis Prevention: a Missed Opportunity?34
The Role of Non-Statin Lipid Lowering Therapies to Reduce ASCVD Events in Primary Prevention34
The Intersection Between COVID-19, Cardiovascular Disease, and Diet: a Review31
RNA Silencing in the Management of Dyslipidemias30
GLP-1 Receptor Agonists and Cardiovascular Disease: What Do Clinicians Need to Know?30
Recent Advances and Perspectives of Metabolomics-Based Investigations in Coronary Heart Disease30
Lipoprotein(a): from Causality to Treatment29
Lipid Lowering Therapy Utilization and Lipid Goal Attainment in Women29
The Role of Sleep in Cardiovascular Disease29
Myeloid Cells in Abdominal Aortic Aneurysm29
Low LDL-C: Is It all Good News?28
Role of RNA-binding Proteins in Regulating Cell Adhesion and Progression of the Atherosclerotic Plaque and Plaque Erosion28
Implications of the Landmark ISCHEMIA Trial on the Initial Management of High-Risk Patients with Stable Ischemic Heart Disease28
The Role of Bacterial Extracellular Membrane Nanovesicles in Atherosclerosis: Unraveling a Potential Trigger28
Update on Plant-Based Diets and Cardiometabolic Risk27
In-Hospital Use of PCSK9 Inhibitors in the Post ACS Patient: What Does the Evidence Show?25
Importance of Nutrition Security to CVD Prevention Efforts in the USA25
Implementing Reporting Standards for Polygenic Risk Scores for Atherosclerotic Cardiovascular Disease25
Coronary Microvascular Dysfunction: What Clinicians and Investigators Should Know24
Stress, Vascular Smooth Muscle Cell Phenotype and Atherosclerosis: Novel Insight into Smooth Muscle Cell Phenotypic Transition in Atherosclerosis24
Novel Therapies for Lipoprotein(a): Update in Cardiovascular Risk Estimation and Treatment24
Transgender Cardiovascular Health: Practical Management for the Clinician24
Effects of Omega-3 Fatty Acids on Flow-mediated Dilatation and Carotid Intima Media Thickness: A Meta-analysis23
Correction to: High-Density Lipoproteins and Serum Amyloid A (SAA)22
Childhood Hypertriglyceridemia: Is It Time for a New Approach?22
Dairy Foods: Is Its Cardiovascular Risk Profile Changing?21
Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?21
Noninvasive Atherosclerotic Phenotyping: The Next Frontier into Understanding the Pathobiology of Coronary Artery Disease20
Do Triglyceride-Rich Lipoproteins Equal Low-Density Lipoproteins in Risk of ASCVD?20
Membrane Cholesterol Interactions with Proteins in Hypercholesterolemia-Induced Endothelial Dysfunction20
Is Family History for the Management of Cardiovascular Health in Youth Still Relevant in Clinical Practice?20
SR-B1’s Next Top Model: Structural Perspectives on the Functions of the HDL Receptor19
Eliminating Health Disparities in Atrial Fibrillation, Heart Failure, and Dyslipidemia: A Path Toward Achieving Pharmacoequity19
Evidence Gaps in Assessments of the Healthiness of Online Supermarkets Highlight the Need for New Monitoring Tools: a Systematic Review19
Major Concepts in Treatment with Bempedoic Acid and Inclisiran that Clinicians Need To Know19
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2024 American College of Cardiology Conference19
Is There a Role for Imaging Youth at Risk of Atherosclerosis?19
Gene Regulatory Networks in Coronary Artery Disease18
Brief Review: Racial and Ethnic Disparities in Cardiovascular Care with a Focus on Congenital Heart Disease and Precision Medicine18
Clinical Management of Dyslipidemia in Infants and Toddlers18
Pharmacotherapy for Coronary Artery Disease and Acute Coronary Syndrome in the Aging Population17
Wall Shear Stress Alteration: a Local Risk Factor of Atherosclerosis17
Cardiovascular Health and Disease in the Pakistani American Population17
Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults16
Targeting the Gut Microbiome to Treat Cardiometabolic Disease16
Bempedoic Acid: for Whom and When16
What Causes Premature Coronary Artery Disease?16
Long-Term Cardiovascular Effects of COVID-19: Emerging Data Relevant to the Cardiovascular Clinician15
High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review15
Inclisiran, Reasons for a Novel Agent in a Crowded Therapeutic Field15
Biology, Bias, or Both? The Contribution of Sex and Gender to the Disparity in Cardiovascular Outcomes Between Women and Men15
Natural Sirtuin1 Activators and Atherosclerosis: an Overview15
Highlights of Cardiovascular Disease Prevention Studies Presented at the 2025 American College of Cardiology Conference15
Non-obstructive Plaque and Treatment of INOCA: More to Be Learned14
Anti-Inflammatory Lipid Mediators from Polyunsaturated Fatty Acids: Insights into their Role in Atherosclerosis Microenvironments14
Management of Hypercholesterolemia in Pregnant Women with Atherosclerotic Cardiovascular Disease14
Managing of Dyslipidaemia Characterized by Accumulation of Triglyceride-Rich Lipoproteins14
A Review of Statin Intolerance: a Focus on Statin-Attributed Muscle Symptoms14
Utility of FFRCT in Patients with Chest Pain14
Extra-coronary Calcification and Cardiovascular Events: What Do We Know and Where Are We Heading?14
Combined Dyslipidemia in Children and Adolescents: a Proposed New Management Approach14
Fixed Combination for the Treatment of Dyslipidaemia13
Pregnancy Complications and Long-Term Atherosclerotic Cardiovascular Disease Risk13
Circular RNA role in Atherosclerosis Development and Progression13
Apheresis: What Should a Clinician Know?13
Managing Dyslipidemia in Chronic Kidney Disease: Implications for Cardiovascular and Renal Risk13
Controversies in the Use of Omega-3 Fatty Acids to Prevent Atherosclerosis13
Unraveling the miRNA Puzzle in Atherosclerosis: Revolutionizing Diagnosis, Prognosis, and Therapeutic Approaches12
Diet, Food Insecurity, and CVD Risk in Sexual and Gender Minority Adults12
LDL-C: The Only Causal Risk Factor for ASCVD. Why Is It Still Overlooked and Underestimated?12
Lipids: a Potential Molecular Pathway Towards Diastolic Dysfunction in Youth-Onset Type 2 Diabetes12
Recent Updates in Hypertriglyceridemia Management for Cardiovascular Disease Prevention12
0.052873134613037